SEARCH:      Monitor Keywords |  Custom RSS

Organic compounds -- part of the class 532-570 series November USPTO class listing 11/08

20080293935 - Method for the production of 2,4,6- trimercapto-1,3,5-triazine: The present invention is directed towards a method for the production of 2,4,6-trimercapto-1,3,5-triazine (TMT-H3). In particular, the method of the subject matter relates to the operation of acidifying the salts of 2,4,6-trimercapto-1,3,5-triazine in aqueous solution and in a defined pH range.... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20080293937 - N-type thiophene semiconductors: The new fluorocarbon-functionalized and/or heterocycle-modified polythiophenes, in particular, α,ω-diperfluorohexylsexithiophene DFH-6T can be straightforwardly prepared in high yield and purity. Introduction of such modifications to a thiophene core affords enhanced thermal stability and volatility, and increased electron affinity versus the unmodified compositions of the prior art. Evaporated films behave as n-type... Agent: Reinhart Boerner Van Deuren S.c. Attn: Linda Kasulke, Docket Coordinator

20080293936 - Novel inhibitors of lysyl oxidase: The present invention concerns novel pyridazine-3-on- and pyrazol-3-on derivatives, methods of synthesizing such, a pharmaceutical agent containing pyridazine-3-on- and pyrazol-3-on derivatives as well as the use of the compounds for the prophylaxis or treatment of fibrotic diseases and/or pathologic remodelling and the use of said compounds for the expansion of... Agent: Elmar Burchardt

20080293938 - Novel process for the preparation of didanosine using novel intermediates: present invention relates to novel crystalline alkali metal and alkaline earth metal salts of 2′,3′-dideoxy-2′,3′-didehydroinosine. The present invention also provides a novel process for preparation of didanosine in high yield and purity using novel intermediates. Thus, for example, 5′-O-acetyl-2′,3′-dideoxy-2′,3′-didehydroinosine is reacted with monomethyl amine to give 2′,3′-dideoxy-2′,3′-didehydro inosine, which is... Agent: Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd.

20080293939 - Quinazolinone derivatives useful as anti-hyperalgesic agents: The present invention relates to quinazolinones of formula (I) wherein R1 is hal; a); b); or c); X is N or CR8; R2 is hal; nitro; C1-C6alkylcarbonyl; C1-C6alkyl or C3-C6cycloalkyl; R3 is C1-C6alkyl; C1-C6alkoxy or amino; and wherein the further radicals have the meanings as defined in the specification, which... Agent: Novartis Corporate Intellectual Property

20080293940 - Amide derivative and medicine: e

20080293941 - Method for production of 1-alkyl-3-phenyluracils:

20080293942 - Methods of preparing 2-imidazol-1-yl-4-methyl-6-pyrrolidin-2-yl-pyrimidine and 4-(1-alkylpyrrolidin-2-yl)-2-(1h-imidazol-1-yl)-6-methylpyrimidine derivatives: The present invention is directed to a novel, high yield method for preparing 2-imidazol-1-yl-4-methyl-6-pyrrolidin-2-yl-pyrimidine, particularly to a method of preparing 4-(1-alkylpyrrolidin-2-yl)-2-(1H-imidazol-1-yl)-6-methylpyrimidine, more particularly, 2-(2-(2-(1H-imidazol-1-yl)-6-methylpyrimidin-4-yl)pyrrolidrn-1-yl)-N-(benzo[d][1,3]dioxol-5-yh-nethyl)-N-methylethanamine. These compounds and pharmaceutical compositions thereof are inhibitors of nitric oxide synthase, are selective for inducible nitric oxide synthase, and are useful in treating diseases and... Agent: Global Patent Group - Kal Attn: Ms Lavern Hall

20080293943 - Process for the preparation of 5-(4-[4-(5-cyano-3-indolyl)butyl]-1-piperazinyl)benzofuran-2-carboxamide: The invention relates to a process for the preparation of 5-(4-[4-(5-cyano-3-indolyl)butyl]-1-piperazinyl)benzofuran-2-carboxamide and/or one of its physiologically acceptable salts, characterised in that a compound of the formula (I), in which L denotes Cl, Br, I, SO2F, SO2CF3, SO2C2F5, is reacted with 3-(4-piperazin-1-ylbutyl)indole-5-carbonitrile by transition-metal-catalysed coupling by means of Pd complexes, and/or... Agent: Millen, White, Zelano & Branigan, P.C.

20080293944 - Piperazinyl compounds: e

20080287676 - Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor: P

20080287677 - Salts of aripiprazole: The present invention relates to acid addition salts of aripiprazole, a process for preparing said acid addition salts and their use to prepare or purify aripiprazole in the form of a free base or in the form of a pharmaceutically acceptable salt.... Agent: Sandoz Inc

20080281095 - Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support: The invention is directed to compounds and methods of synthesizing hydroxyethlamino amides and their use in treatment of aspartyl protease mediated diseases and conditions.... Agent: Philip S. Johnson Johnson & Johnson

20080281096 - Resolution process for preparing (+)-2s,3s)-2-(3-chlorophenyl)-3,3,3-trimethyl-2-morpholinol: Disclosed is a method for preparing (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol and pharmaceutically acceptable salts such as the (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol hydrochloride salt via dynamic kinetic resolution.... Agent: Glaxosmithkline Corporate Intellectual Property, Mai B482

20080281097 - Process for preparing an angiotensin ii receptor antagonist: Process for preparing angiotensin II receptor antagonists, in particular irbesartan, protected forms for the preparation thereof, or a pharmaceutically acceptable salt thereof, that comprises the reaction between a biphenylamino derivative and an oxazolone derivative. New intermediates are useful for the preparation of angiotensin II receptor antagonists.... Agent: Berenbaum, Weinshienk & Eason, P.c

20080281098 - Organometallic compounds and emission-shifting organic electrophosphorescence: Emissive phosphorescent organometallic compounds are described that produce improved electroluminescence, particularly in the blue region of the visible spectrum. Organic light emitting devices employing such emissive phosphorescent organometallic compounds are also described. Also described is an organic light emitting layer including a host material having a lowest triplet excited state... Agent: Kenyon & Kenyon LLP

20080281099 - Process for purifying valacyclovir hydrochloride and intermediates thereof: The invention relates to processes for the purification of valacyclovir hydrochloride and intermediates thereof.... Agent: Dr. Reddy's Laboratories, Inc.

20080281100 - Pure paliperidone and processes for preparing thereof: The present invention provides pure paliperidone comprising less than about 0.1%, preferably less than about 0.05% and more preferably less than about 0.02%, impurity X as well as purification processes to obtain thereof.... Agent: Kenyon & Kenyon LLP

20080281101 - Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin: There is provided a process for the preparation of a compound of formula (7): formula (7) wherein R1 represents an alkyl group; R2 represents an aryl group; R3 represents hydrogen, a protecting group or an alkyl group; and R4 represents hydrogen, a protecting group or a SO2R5 group where R5... Agent: Foley Hoag, LLP Patent Group, World Trade Center West

20080281102 - Methods and compounds for preparing cc-1065 analogs: A method of forming a CBI CC-1065 analog utilizes NH2 as a starting material, where R3 is H or alkyl and R6 is H, substituted or unsubstituted lower alkyl, cyano, or alkoxy. Intermediates (I) are used and are claimed.... Agent: Medarex C/o Darby & Darby P.C.

20080275233 - Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease: The invention encompasses ureido substituted benzoic acid compounds, compositions comprising the compounds and methods for treating or preventing diseases associated with nonsense mutations of mRNA by administering these compounds or compositions.... Agent: Jones Day

20080275234 - Method for producing pure melamin: The invention relates to a method for producing pure melamine by preparing a melamine melt, which is obtained in a high pressure process and from which the reaction gases are removed. Said method is characterized in that the melamine melt is quenched by water with a purity in excess of... Agent: The Webb Law Firm, P.C.

20080275235 - Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors: Novel fused heteroaromatic compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor (“TGF”)- signaling pathway. They are useful in the treatment of various TGF-related disease... Agent: Pharmacia & Upjohn

20080275236 - Method for removing salts from a reaction mixture containing alkoxycarbonyl amino triazine: The invention relates to a process for removing salts from an alkanolic reaction mixture which is obtained in the preparation of alkoxycarbonylaminotriazines and comprises at least one alkoxycarbonylaminotriazine, at least one cyclic and/or acyclic carbonic ester, at least one C1-C13-alkanol which optionally comprises one or two oxygen atoms as ether... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20080275237 - Method for obtaining pure tetrahydrocannabinol: The invention relates to a method for obtaining pure tetrahydrocannabinol from reaction mixtures containing tetrahydrocannabinol compounds or from raw products containing tetrahydrocannabinol compounds. According to said method, the tetrahydrocannabinol compounds in the reaction mixture or in the raw product are converted into crystallisable derivatives, preferably using a suitable solvent, said... Agent: Hammer & Associates, P.C.

20080275238 - Substituted heterocyclic compounds: e